Filtros : "Frontiers Pharmacology" Removido: "Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)" Limpar

Filtros



Refine with date range


  • Source: Frontiers Pharmacology. Unidade: IQ

    Subjects: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 01 nov. 2024. , 2024
    • APA

      Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
    • NLM

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
    • Vancouver

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
  • Source: Frontiers Pharmacology. Unidade: FCF

    Subjects: MICRORNAS, AGENTES HEPATOTÓXICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DE FREITAS, Renata Caroline Costa et al. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells. Frontiers Pharmacology, v. 8, p. 1-11 art.906, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00906. Acesso em: 01 nov. 2024.
    • APA

      De Freitas, R. C. C., Bortolin, R. H., Lopes, M. B., Tamborlin, L., Meneguello, L., Silbiger, V. N., et al. (2017). Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells. Frontiers Pharmacology, 8, 1-11 art.906. doi:10.3389/fphar.2017.00906
    • NLM

      De Freitas RCC, Bortolin RH, Lopes MB, Tamborlin L, Meneguello L, Silbiger VN, Hirata RDC, Hirata MH, Luchessi AD, Luchessi AD. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells [Internet]. Frontiers Pharmacology. 2017 ; 8 1-11 art.906.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2017.00906
    • Vancouver

      De Freitas RCC, Bortolin RH, Lopes MB, Tamborlin L, Meneguello L, Silbiger VN, Hirata RDC, Hirata MH, Luchessi AD, Luchessi AD. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells [Internet]. Frontiers Pharmacology. 2017 ; 8 1-11 art.906.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2017.00906

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024